IACS-13909
IACS-13909 is a selective, potent and orally active SHP2 allosteric inhibitor with an IC50 of 15.7 nM and a Kd of 32 nM. IACS-13909 is more selective for SHP2 than other phosphatases (including SHP1) . IACS-13909 has antitumor activities and suppresses MAPK pathway signaling in receptor tyrosine kinases (RTK) -dependent cancers[1].
Product Specifications
CAS Number
[2160546-07-4]
UNSPSC
12352005
Target
Phosphatase; SHP2
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/iacs-13909.html
Concentration
10mM
Purity
99.97
Solubility
DMSO : 10 mg/mL (ultrasonic)
Smiles
NC1(C)CCN(C2=CN=C3C(NN=C3C4=CC=CC(Cl)=C4Cl)=N2)CC1
Molecular Formula
C17H18Cl2N6
Molecular Weight
377.27
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
ZNF76 (Zinc Finger Protein 76, Zinc Finger Protein 523, ZNF76, D6S229E, ZNF523) (FITC)
ZNF76 (Zinc Finger Protein 76, Zinc Finger Protein 523, ZNF76, D6S229E, ZNF523) (FITC)
LEF1, NT (LEF1, Lymphoid enhancer-binding factor 1, T cell-specific transcription factor 1-alpha) (APC) discontinued